She states her BP was low at baseline 85 systolic until that time until 21 weeks when blood pressure noted to increase to 120 systolics.
Urine protein was reported as negative at that time.
She reports that her BP remained elevated post-partum SBP 130-160's and she was prescribed nifedipine 30mg on [**4-5**].
BP continued to remain at 160-170 systolic.
Her BP was found to be elevated 160/80 HR 130 at around 7:10 am.
In the ED, VS T 98.6 HR 130 BP 162/108 RR 16 100% on RA.
Labs showed Prot/Cr:7.4, mg 2.9 (after mag given).
She was given magnesium sulfate 2g load and was started on an infusion 2g/hour, 1mg ativan was also given and 10mg labetolol x 1, then 20 mg IV x 1 with BP to 146/97.
CT head negative for bleed, mass.
Past Medical History: G1P1 induced labor for pre-eclampsia [**2170-3-31**]  Social History: Pt is from [**Country 11150**].
Physical Exam: Vitals: T 99.2 HR 87 BP 162/95 RR 15 99% on RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, PERRL, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, ronchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CN 2-12 intact and symmetric.
Pertinent Results: [**2170-4-7**] 05:30PM   MAGNESIUM-5.6* [**2170-4-7**] 10:03AM URINE  HOURS-RANDOM CREAT-11 TOT PROT-81 PROT/CREA-7.4* [**2170-4-7**] 08:30AM URINE  BLOOD-LG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG [**2170-4-7**] 08:00AM   GLUCOSE-90 UREA N-10 CREAT-0.7 SODIUM-142 POTASSIUM-3.7 CHLORIDE-107 TOTAL CO2-24 ANION GAP-15 [**2170-4-7**] 08:00AM   ALT(SGPT)-21 AST(SGOT)-20 LD(LDH)-298* ALK PHOS-128* TOT BILI-0.5 [**2170-4-7**] 08:00AM   ALBUMIN-3.6 CALCIUM-9.5 PHOSPHATE-3.2 MAGNESIUM-2.9* URIC ACID-6.8* [**2170-4-7**] 08:00AM   WBC-10.2 RBC-4.29 HGB-13.1 HCT-39.0 MCV-91 MCH-30.6 MCHC-33.6 RDW-13.2 [**2170-4-7**] 08:00AM   NEUTS-69.7 LYMPHS-23.7 MONOS-3.7 EOS-2.2 BASOS-0.7 [**2170-4-7**] 08:00AM   PLT COUNT-415 [**2170-4-9**] 06:30AM BLOOD WBC-7.0 RBC-3.71* Hgb-11.8* Hct-35.2* MCV-95 MCH-31.9 MCHC-33.7 RDW-13.3 Plt Ct-385 [**2170-4-8**] 03:01AM BLOOD WBC-8.8 RBC-4.12* Hgb-12.9 Hct-37.3 MCV-91 MCH-31.3 MCHC-34.6 RDW-13.4 Plt Ct-430 [**2170-4-9**] 06:30AM BLOOD Plt Ct-385 [**2170-4-8**] 03:01AM BLOOD Plt Ct-430 [**2170-4-9**] 06:30AM BLOOD Creat-0.7 [**2170-4-8**] 03:01AM BLOOD Glucose-86 UreaN-11 Creat-0.7 Na-134 K-3.4 Cl-101 HCO3-22 AnGap-14 [**2170-4-9**] 06:30AM BLOOD ALT-13 [**2170-4-8**] 03:01AM BLOOD ALT-15 AST-16 LD(LDH)-249 AlkPhos-122* TotBili-0.5 [**2170-4-9**] 06:30AM BLOOD UricAcd-5.6 [**2170-4-8**] 03:01AM BLOOD Calcium-7.7* Phos-4.2 Mg-7.7* UricAcd-6.8*  CT HEAD W/O CONTRAST Study Date of [**2170-4-7**] 8:37 AM:  FINDINGS: There is no evidence of acute hemorrhage, edema, large masses or mass effect.
No metabolic disorders, no illicit drug use, no evidence of acute stroke based on CT head, no clear infection OBGYN and Neurology were consulted in the ED.
They recommended magnesium sulfate x24 hours @ 2g/hour, monitoring reflexes q4 hours, decreased UO, hypoxia, chest pain to assess for toxicity, calcium gluconate 1g IV to counteract magnesium toxicity if occurs.
Per OBGYN recs, short-acting calcium channel blockers are not advised in the setting of Magnesium sulfate infusion.
Also initiated an infectious work up for seizures including CXR, blood cultures, urine culture, would consider LP if refractory.
Siezure attributed to eclampsia with elevated blood pressure and protein creatine ratio of 7.4.
Daily preclampsia labs were checked which normalized.
Blood pressures remained well controlled on Labetalol 200mg PO BID.
WBC at the time was 10.2.
Chest XRay was negative for pneumonia.
Urine analysis and culture were negative.
Blood cultures remain pending.
Please also call if you blood pressure is > 140/90 or if you have any other concerns.
Phone: [**Telephone/Fax (1) 82181**]  2.
